Home › Forums › Main Forum › FixHepC Admin › Gilead- Evil in the Form of Greed!!
- This topic has 24 replies, 11 voices, and was last updated 8 years, 6 months ago by Ariel.
-
AuthorPosts
-
14 April 2016 at 5:33 am #15440
Gilead, one of the ugliest and greediest company’s known in the entire world!! Luckily for many of us there are company’s who are making generics and there are plenty of people and doctors who see that treating people who cant afford Gilead’s price tag as an unfair practice and do what they can to balance the scales. I salute GP2U and fix HepC buyers club for all the assistance they have given and continue to give to the world of HepC and patients in need. With that said, I started this thread to post pictures or drawings of company’s like Gilead, in other words what visual comes up when you think of a greedy company?? Post what you want, all I ask is that you keep it real. Here’s my little pic! Actually, I have two pics, but I’ll post the other one later!! ~Cheers!!
http://www.theatlantic.com/health/archive/2015/09/an-expensive-medications-human-cost/407299/
G1a dx’d in 1992, Biopsy F2 VL 8mill +. Tried tx with Interferon/Riba, back in 2008 didn’t last long it felt horribly ugly!! I stopped tx, after 5 weeks!!
Started tx 6/1/16 with Harvoni.
12 Month Labs= UND14 April 2016 at 5:45 am #15441The Greediad motto:
“We will trade your life for your life savings, first born and left nut” (if you have a pair) If not, I suppose a left boob would do…
Despicable
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2414 April 2016 at 5:47 am #1544214 April 2016 at 8:10 am #1545314 April 2016 at 8:50 am #15458I hope one of our Senators or State legislators writes something up to keep companies from over charging for drugs the way Gilead has. Australia came out of it pretty good and got Gilead to lower their prices substantially. Of course location is everything and Qz is in a good part of the world to take advantage of the generics being made. Unfortunately, I don’t think anyone in the US will be able to do anything about it, at least not anytime soon and more lives will be lost and Gilead will keep counting their profits all the way to the bank!!!!!!!!!!!!!!!! That little freakazoid down there is the way I think Gilead looks. How about you, any pics?
G1a dx’d in 1992, Biopsy F2 VL 8mill +. Tried tx with Interferon/Riba, back in 2008 didn’t last long it felt horribly ugly!! I stopped tx, after 5 weeks!!
Started tx 6/1/16 with Harvoni.
12 Month Labs= UND14 April 2016 at 9:12 am #15459I am trying to post a picture of the ferngully monster, have attached and submitted a few times, even tried to paste screen shot. Look it up someone more adept than me while I keep trying.
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
14 April 2016 at 10:25 am #15461This one?
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
14 April 2016 at 11:43 am #15464That’s it! Was the monsterfication of corporate greed and destruction in the environment. jumped to mind when I saw the thread’s name.
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
14 April 2016 at 12:10 pm #15465Hi Joy Your link is “currently under maintenance” so I will have to read it later..
YMMV
14 April 2016 at 3:02 pm #15474It’s back up now Lynne. A sickening read really.
Gilead keeps Martin’s pay at $18.8M in last year as CEO.
Gilead Sciences CEO John Martin isn’t strapped for cash. The exec has added about $18 million in annual compensation each year to his coffers, not to mention hundreds of millions in stock gains since he came on board in 2009. This year wasn’t any different. Martin took home a hefty pay package as the company’s hep C franchise kept delivering the cash–even though it lost some momentum in the U.S. at the same time.
http://www.fiercepharma.com/financials/gilead-keeps-martin-s-pay-at-18-8m-last-year-as-ceo
14 April 2016 at 7:06 pm #15482Gilead is a hedge fund under the guise of a pharmaceutical company. They want drugs that will treat diseases that are problems in wealthy, industrialized nations. Don’t look for them to come up with a cure for malaria, ebola or Zika-there is just not enough money in it for them to be interested.
They will continue to tend the geese that lay the golden eggs until, like Australia, they are forced to “make the deal”. Then they will cook and eat them.
In the U.S., insurers are relaxing restrictions because of legal pressure brought about by patients over denial of treatment. This will force substantial rises in the cost of health insurance for everyone, with Gilead getting the money. Health insurance companies don’t go broke. They have reserve funds, and when they have to tap into them one year, they raise the premiums the next to cover the shortfall.
Widespread acceptance of affordable generics is the only way Greediad will have its hand forced.
We are in a high stakes poker game here. The insurance companies are the “house”. Gilead, the well-funded, card-counting professional gambler.
We are the chips.
M
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2414 April 2016 at 10:53 pm #15489I remember back in the nineteen seventies when we were all growing up, “Career of Evil” was just a dark song on a concept album with cool guitar riffs:
So much for progress?
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).15 April 2016 at 4:16 am #15501Gilead are evil bastards!
Attachments:15 April 2016 at 5:11 am #15502I’ve asked my lecturer to explain to me why their corporate conduct does not constitute murder. And how can their objective, of maximum profit for shareholders, be lawful if deaths result from their decisions. Crime is an act or omission. Because paying yourself so much, like Martin, is hardly maximising profits to (other) shareholders, it’s unreasonable. The objective’s not being upheld in that respect; how can it be a justification in pricing. Plus, there was another way to achieve the same profit- cure much more people for much less, same revenue- but they have meeting records that seem to show they thought the inevitable deaths, from their pricing strategy decisions, are commercially useful.
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
15 April 2016 at 5:23 am #15503Hi Hazelriannon,
They can do it because of the TRUE golden rule…
He who has the Gold, makes the rules.
-
AuthorPosts
- You must be logged in to reply to this topic.